TOPIC

API News & Analysis

Pharmacy wars: Sigma tops Wesfarmers bid for API
Stocks
Pharmacy wars: Sigma tops Wesfarmers bid for API
But the tie-up could face significant hurdles, says Morningstar analysts.  
Emma Rapaport | 29 September 2021
What top Australian equity managers bought and sold last quarter
Funds
What top Australian equity managers bought and sold last quarter
Spark Infrastructure, CSL and Australian Pharmaceuticals among the names picked up between April and June.
Lewis Jackson | 16 July 2021
3 Aussie healthcare plays to watch
Stocks
3 Aussie healthcare plays to watch
The corona sell-off has unearthed discounts among makers of gloves, pharmaceutical goods and spray-on skin technology.
Lex Hall | 18 March 2020
Coronavirus effect: 11 Aussie stocks to watch
Stocks
Coronavirus effect: 11 Aussie stocks to watch
At the time of writing, a Morningstar screener shows 11 Australian stocks currently in five-star territory.
Lex Hall | 04 March 2020
6 healthcare buys spanning Australia, US
Stocks
6 healthcare buys spanning Australia, US
Though Morningstar views the healthcare sectors in both the US and Australia as fairly valued overall, there is a handful of buying opportunities...
Glenn Freeman | 10 July 2019
Australian undervalued defensive stocks in healthcare
Stocks
Australian undervalued defensive stocks in healthcare
Australian hospital operator Healius and equipment provider Fisher and Paykel are among a list of defensive plays that are trading at a discount.
Lex Hall | 29 May 2019
API offers $727m for Sigma Healthcare
Stocks
API offers $727m for Sigma Healthcare
Drug distributor Australian Pharmaceutical Industries has offered about $727 million to buy all of rival Sigma Healthcare, aiming to consolidate in...
AAP | 14 December 2018